Goodyear, Carl S;
Patel, Amit;
Barnes, Eleanor;
Willicombe, Michelle;
Siebert, Stefan;
de Silva, Thushan I;
Snowden, John A;
... OCTAVE-DUO investigators; + view all
(2024)
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
The Lancet Rheumatology
10.1016/S2665-9913(24)00065-1.
(In press).